International Journal of Radiation Oncology * Biology * Physics
Volume 44, Issue 2 , Pages 413-419 , May 1999

Association of increased radiocurability of murine carcinomas with low constitutive expression of p21WAF1/CIP1 protein

  • Tetsuo Akimoto, M.D.

      Affiliations

    • Department of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Jinsil Seong, M.D., Ph.D.

      Affiliations

    • Department of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Nancy R Hunter, M.S.

      Affiliations

    • Department of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Lara Buchmiller, B.S.

      Affiliations

    • Department of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Kathy Mason, M.S.

      Affiliations

    • Department of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Luka Milas, M.D., Ph.D.

      Affiliations

    • Department of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    • Corresponding Author InformationReprint requests to: Luka Milas, M.D., Ph.D, Department of Experimental Radiation Oncology - 066, 1515 Holcombe Boulevard, Houston, TX 77030-4095

,Accepted 8 January 1999.

References 

  1. Kastan MB, Oneykwere O, Sidransky D, et al.  Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991;51:6304–6311
  2. Lowe SW, Ruley HE, Jacks T, et al.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 1993;74:957–967
  3. El-Deiry WS, Tolino T, Velculescu VE, et al.  WAF-1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817–825
  4. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human BAX gene. Cell. 1995;80:293–299
  5. Kobayashi T, Ruan S, Jabbur JR, et al.  Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fax/APO-1 by irradiation and ara-C treatment. Cell Death Differ. 1998;5:584–591
  6. Korsmeyer SJ, Shulter JR, Veis DJ, et al.  Bcl-2/Bax (A homeostat that regulates an anti-oxidant pathway and cell death). Semin Cancer Biol. 1993;4:327–332
  7. Reed JC. Double identity for proteins of the Bcl-2 family. Nature. 1997;387:773–776
  8. Lee JM, Berstein A. p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA. 1993;90:5742–5746
  9. Mellwrath AJ, Vasey PA, Ross GM, et al.  Cell cycle arrests and radiosensitivity of human cell lines (Dependence on wild-type p53 for radiosensitivity). Cancer Res. 1994;54:3718–3722
  10. Harris MB, Canman CE, Leonard CJ. P53, cell cycle control and apoptosis (Implication for cancer). Cancer Metastasis Rev. 1995;14:3–15
  11. Smith ML, Fornace AJ. The two faces of tumor suppressor p53. Am J Pathol. 1996;148:1019–1022
  12. Hawkins DS, Demers W, Galloway DA. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res. 1996;56:892–898
  13. Fan S, Smith ML, Rivet I, et al.  Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res. 1995;55:1649–1654
  14. Brachman DG, Becket M, Graves D, et al.  P53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res. 1993;53:3667–3669
  15. Zhang W, Kornblau SM, Kobayashi T, et al.  High levels of constitutive WAF1/CIP1 protein are associated with chemoresistance in acute myelogenous leukemia. Clin Cancer Res. 1995;1:1051–1057
  16. Waldman T, Lengauer C, Kinzler KW, et al.  Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking WAF1/CIP1. Nature. 1996;381:713–716
  17. Fan S, Chang JK, Smith ML, et al.  Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene. 1997;14:2128–2136
  18. Saito Y, Milross CG, Hittelman WN, et al.  Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction. Int J Radiat Oncol Biol Phys. 1997;38:623–631
  19. Waldman T, Zhang Y, Dillehay L, et al.  Cell-cycle arrest versus cell death in cancer therapy. Nature Med. 1997;3:1034–1036
  20. Wouters BG, Giaccia AJ, Denko NC, et al.  Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res. 1997;57:4703–4706
  21. Ruan S, Okcu F, Ren JP, et al.  Overexpressed WAF1/CIP1 renders glioblastoma cells resistant to chemotherapy agent 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. Cancer Res. 1998;58:1538–1543
  22. Gorospe M, Wang X, Guyton KZ, et al.  Prospective role of p21(Waf1/Cip1) protects against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol Cell Biol. 1996;16:6654–6660
  23. Gorospe M, Cirielli C, Wang X, et al.  p21(WAF1/CIP1) protects p53-mediated apoptosis of human melanoma cells. Oncogene. 1997;14:929–935
  24. Milas L, Hunter N, Mason KA, et al.  Immunological resistance to pulmonary metastases in C3Hf/Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res. 1974;34:61–71
  25. Milas L, Wike J, Hunter N, et al.  Macrophage content of murine sarcomas and carcinomas (Associations with tumor growth parameters and tumor radiocurability). Cancer Res. 1987;47:1069–1075
  26. Suit H, Allam A, Allalunis-Turner J, et al.  Is tumor cell radiation resistance correlated with metastatic ability?. Cancer Res. 1994;54:1736–1741
  27. Milas L, Hunter NR, Mason KA, et al.  Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res. 1995;55:3564–3568
  28. Finney DJ. Quantal response and the tolerance distribution. In: Statistical methods in biological assay. London: Griffen; 1952;p. 454–456
  29. Stephens LC, Ang KK, Schultheiss TE, et al.  Apoptosis in irradiated murine tumor. Radiat Res. 1991;127:308
  30. Stephens LC, Hunter NR, Ang KK, et al.  Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat Res. 1993;135:75–80
  31. Meyn RE, Stephens LC, Ang KK, et al.  Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol. 1993;64:583–591
  32. Schimming R, Mason KA, Hunter N, et al.  Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel. Cancer Chemother Pharmacol. 1998;43:165–172
  33. Zhang H, Hannon GJ, Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 1994;8:1750–1758
  34. Hill RP, Ng R, Warren BF, et al.  The effect of intercellular contact on the radiation sensitivity of KHT sarcoma cells. Radiat Res. 1979;77:182–192
  35. Sutherland RM. Cell and environment interactions in tumor microregions (The multicell spheroid model). Science. 1988;240:177–184
  36. Michieli P, Chedid MDL, Pierce JH, et al.  Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 1994;54:3391–3395
  37. Halevy O, Novitch BG, Spicer DB, et al.  Correlation of terminal cell-cycle arrest of skeletal-muscle with induction of p21 by MyoD. Science. 1995;267:1018–1021
  38. Zhang W, Grasso L, McClain CD, et al.  p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res. 1995;55:668–674
  39. Qiu X, Forman HJ, Schonthal AH, et al.  Induction of p21 mediated by reactive oxygen species formed during the metabolism of aziridinylbenzoquinones by HCT116 cells. J Biol Chem. 1996;271:31915–31921

☆ This work was supported by National Institutes of Health research grants CA-06294 and CA-16672.

PII: S0360-3016(99)00022-X

International Journal of Radiation Oncology * Biology * Physics
Volume 44, Issue 2 , Pages 413-419 , May 1999

Article Tools

* Image Usage & Resolution